scholarly journals Group dynamics are associated with weight loss in the behavioral treatment of obesity

Obesity ◽  
2015 ◽  
Vol 23 (8) ◽  
pp. 1563-1569 ◽  
Author(s):  
Lisa M. Nackers ◽  
Pamela J. Dubyak ◽  
Xiaomin Lu ◽  
Stephen D. Anton ◽  
Gareth R. Dutton ◽  
...  
Keyword(s):  
Weight Loss ◽  
Group Dynamics ◽  
Behavioral Treatment ◽  
Treatment Of Obesity

scholarly journals Cognitive-Behavioral Strategies to Increase the Adherence to Exercise in the Management of Obesity

2011 ◽  
Vol 2011 ◽  
pp. 1-11 ◽  
Author(s):  
Riccardo Dalle Grave ◽  
Simona Calugi ◽  
Elena Centis ◽  
Marwan El Ghoch ◽  
Giulio Marchesini
Keyword(s):  
Physical Activity ◽  
Weight Loss ◽  
Weight Control ◽  
Behavioral Treatment ◽  
Cognitive Behavioral ◽  
Healthy Weight ◽  
Behavioral Strategies ◽  
The Difference ◽  
Treatment Of Obesity

Physical activity plays a major role in the development and management of obesity. High levels of physical activity provide an advantage in maintaining energy balance at a healthy weight, but the amount of exercise needed to produce weight loss and weight loss maintenance may be difficult to achieve in obese subjects. Barriers to physical activity may hardly be overcome in individual cases, and group support may make the difference. The key role of cognitive processes in the failure/success of weight management suggests that new cognitive procedures and strategies should be included in the traditional behavioral treatment of obesity, in order to help patients build a mindset of long-term weight control. We reviewed the role of physical activity in the management of obesity, and the principal cognitive-behavioral strategies to increase adherence to exercise. Also in this area, we need to move from the traditional prescriptive approach towards a multidisciplinary intervention.

The behavioral treatment of obesity.

2001 ◽  
Vol 2 (2) ◽  
pp. 133-140 ◽  
Author(s):  
Drew A. Anderson ◽  
Jennifer R. Shapiro ◽  
Jennifer D. Lundgren
Keyword(s):  
Behavioral Treatment ◽  
Treatment Of Obesity

Liraglutide for the Treatment of Obesity: Analyzing Published Reviews

2019 ◽  
Vol 25 (15) ◽  
pp. 1783-1790 ◽  
Author(s):  
Rosario Pastor ◽  
Josep A. Tur
Keyword(s):  
Weight Loss ◽  
Clinical Trials ◽  
Systematic Reviews ◽  
Randomized Clinical Trials ◽  
Statistical Tests ◽  
Overweight And Obesity ◽  
Cochrane Library ◽  
Medical Subject Headings ◽  
Mesh Terms ◽  
Treatment Of Obesity

Background: Several drugs have been currently approved for the treatment of obesity. The pharmacokinetic of liraglutide, as well as the treatment of type 2 diabetes mellitus, have been widely described. Objective: To analyze the published systematic reviews on the use of liraglutide for the treatment of obesity. Methods: Systematic reviews were found out through MEDLINE searches, through EBSCO host and the Cochrane Library based on the following terms: "liraglutide" as major term and using the following Medical Subject Headings (MesH) terms: "obesity", "overweight", "weight loss". A total of 3 systematic reviews were finally included to be analyzed. Results: From the three systematic reviews selected, only two included the randomized clinical trials, while the third study reviewed both randomized and non-randomized clinical trials. Only one review performed statistical tests of heterogeneity and a meta-analysis, combining the results of individual studies. Another review showed the results of individual studies with odds ratio and confidence interval, but a second one just showed the means and confidence intervals. In all studies, weight loss was registered in persons treated with liraglutide in a dose dependent form, reaching a plateau at 3.0 mg dose, which was reached just in men. Most usual adverse events were gastrointestinal. Conclusion: More powerful and prospective studies are needed to assess all aspects related to liraglutide in the overweight and obesity treatment.

scholarly journals Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets

2007 ◽  
Vol 85 (6) ◽  
pp. 1465-1477 ◽  
Author(s):  
Julia A Ello-Martin ◽  
Liane S Roe ◽  
Jenny H Ledikwe ◽  
Amanda M Beach ◽  
Barbara J Rolls
Keyword(s):  
Weight Loss ◽  
Energy Density ◽  
Dietary Energy ◽  
Treatment Of Obesity ◽  
Dietary Energy Density

Infant Obesity, Weight Reduction with Normal Increase in Linear Growth and Fat-free Body Mass

PEDIATRICS ◽  
1992 ◽  
Vol 89 (1) ◽  
pp. 143-145
Author(s):  
JOYCE M. PEIPERT ◽  
VIRGINIA A. STALLINGS ◽  
GERARD T. BERRY ◽  
JULE ANNE D. HENSTENBURG
Keyword(s):  
Weight Loss ◽  
Body Mass ◽  
Weight Maintenance ◽  
Caloric Intake ◽  
Resting Energy Expenditure ◽  
Induce Weight Loss ◽  
Infant Obesity ◽  
Normal Increase ◽  
Free Body ◽  
Treatment Of Obesity

Dietary caloric restriction, as a means to induce weight loss, is seldom used as a treatment of obesity in infancy for fear that permanent stunting of growth may result.1-4 Thus, there is little information on controlled weight loss as the treatment for infant obesity or, more importantly, its effect on growth in length, head circumference, and fat-free body mass during weight loss.5 We present a case of an obese infant who, secondary to a metabolic disorder, required nutritional support both intravenously and by nasogastric tube. During 15 months, the patient's resting energy expenditure (REE) was measured to determine an appropriate caloric intake to promote weight loss and later weight maintenance.

Behavioral Treatment of Obesity

1987 ◽  
Vol 9 (1) ◽  
pp. 20-24 ◽  
Author(s):  
Robert M. Jeffery
Keyword(s):  
Behavioral Treatment ◽  
Treatment Of Obesity

scholarly journals Group-Based Trajectory Analysis of Physical Activity Change in a US Weight Loss Intervention

2018 ◽  
Vol 15 (11) ◽  
pp. 840-846 ◽  
Author(s):  
Christopher C. Imes ◽  
Yaguang Zheng ◽  
Dara D. Mendez ◽  
Bonny J. Rockette-Wagner ◽  
Meghan K. Mattos ◽  
...  
Keyword(s):  
Physical Activity ◽  
Body Mass Index ◽  
Weight Loss ◽  
Body Mass ◽  
Behavioral Treatment ◽  
Group Membership ◽  
Multinomial Logistic Regression ◽  
Step Count ◽  
Weight Loss Intervention ◽  
Trajectory Group

Background: The obesity epidemic is a global concern. Standard behavioral treatment including increased physical activity, reduced energy intake, and behavioral change counseling is an effective lifestyle intervention for weight loss. Purpose: To identify distinct step count patterns among weight loss intervention participants, examine weight loss differences by trajectory group, and examine baseline factors associated with trajectory group membership. Methods: Both groups received group-based standard behavioral treatment while the experimental group received up to 30 additional, one-on-one self-efficacy enhancement sessions. Data were analyzed using group-based trajectory modeling, analysis of variance, chi-square tests, and multinomial logistic regression. Results: Participants (N = 120) were mostly female (81.8%) and white (73.6%) with a mean (SD) body mass index of 33.2 (3.8) kg/m2. Four step count trajectory groups were identified: active (>10,000 steps/day; 11.7%), somewhat active (7500–10,000 steps/day; 28.3%), low active (5000–7500 steps/day; 27.5%), and sedentary (<5000 steps/day; 32.5%). Percent weight loss at 12 months increased incrementally by trajectory group (5.1% [5.7%], 7.8% [6.9%], 8.0% [7.4%], and 13.63% [7.0%], respectively; P = .001). At baseline, lower body mass index and higher perceived health predicted membership in the better performing trajectory groups. Conclusions: Within a larger group of adults in a weight loss intervention, 4 distinct trajectory groups were identified and group membership was associated with differential weight loss.

scholarly journals α-Methyl-L-Tryptophan as a Weight-Loss Agent in Multiple Models of Obesity in Mice

2021 ◽  
Author(s):  
Sathish Sivaprakasam ◽  
Sabarish Ramachandran ◽  
Mohd Omar Faruk Sikder ◽  
Yangzom Doma Bhutia ◽  
Mitchell Wachtel ◽  
...  
Keyword(s):  
Weight Loss ◽  
High Fat Diet ◽  
Amino Acid Profile ◽  
Normal Diet ◽  
The Body ◽  
Multiple Models ◽  
High Fat ◽  
Liver And Kidney ◽  
Obesity In Mice ◽  
Treatment Of Obesity

a-Methyl-L-tryptophan (a-MLT) is currently in use as a tracer in its 11C-labeled form to monitor the health of serotonergic neurons in humans. In the present study, we found this compound to function as an effective weight-loss agent at pharmacological doses in multiple models of obesity in mice. The drug was able to reduce the body weight when given orally in drinking water (1 mg/ml) in three different models of obesity: normal mice on high-fat diet, Slc6a14-null mice on high-fat diet, and ob/ob mice on normal diet. Only the L-enantiomer (a-MLT) was active while the D-enantiomer (a-MDT) had negligible activity. The weight-loss effect was freely reversible, with the weight gain resuming soon after the withdrawal of the drug. All three models of obesity were associated with hyperglycemia, insulin resistance, and hepatic steatosis; a-MLT reversed these features. There was a decrease in food intake in the treatment group. Mice on a high-fat diet showed decreased cholesterol and protein in the serum when treated with a-MLT; there was however no evidence of liver and kidney dysfunction. Plasma amino acid profile indicated a significant decrease in the levels of specific amino acids, including tryptophan; but the levels of arginine were increased. We conclude that a-MLT is an effective, reversible, and orally active drug for the treatment of obesity and metabolic syndrome.

Sign in / Sign up

Export Citation Format

Share Document